Skip to content

Clinical trials

Phase 2 Liver Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20141
20161
20191
20201
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AusperBio Therapeutics Inc.1
Boehringer Ingelheim1
Sagimet Biosciences Inc.1
Second Military Medical University1
Shandong Cancer Hospital and Institute1
Sichuan Cancer Hospital and Research Institute1
Tang-Du Hospital1
Wenzhou Medical University1
West China Hospital1
Xiamen Amoytop Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases10
Carcinoma, Hepatocellular3
Carcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Hepatitis, Chronic2
Hepatitis, Viral, Human2
Liver Neoplasms2
Virus Diseases2
Adenocarcinoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.